Company Filing History:
1 out of 1,289 
Years Active: 2022-2025
Title: Florian Meier: Innovator in Quantitative Proteomics
Introduction
Florian Meier is a notable inventor based in Pullach, Germany. He has made significant contributions to the field of quantitative proteomics, focusing on innovative methods and compounds that enhance mass spectrometry analysis. With a total of 2 patents, his work is paving the way for advancements in proteomic research.
Latest Patents
Florian Meier's latest patents include a "Low energy cleavable mass tag for quantitative proteomics." This invention relates to a compound that features a reactive moiety capable of forming a covalent bond with a peptide's functional group. The compound is designed to fragment in a mass spectrometer at lower energy levels than those required for peptide fragmentation, thus improving the efficiency of mass spectrometry analysis.
Another significant patent is focused on "Uses of isobaric tags in mass spectrometry." This invention describes the application of an isobaric label in mass spectrometry analysis using data-independent acquisition (DIA). The isobaric label is engineered to fragment at lower energy levels than analyte-derived precursor ions, enhancing the accuracy and reliability of mass spectrometry results.
Career Highlights
Florian Meier is associated with the Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V., a prestigious research organization in Germany. His work at this institution has allowed him to explore and develop innovative solutions in the field of proteomics.
Collaborations
Throughout his career, Florian has collaborated with esteemed colleagues such as Sebastian Virreira Winter and Arturo Zychlinsky. These collaborations have contributed to the advancement of research in quantitative proteomics and mass spectrometry.
Conclusion
Florian Meier's contributions to the field of quantitative proteomics through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence advancements in mass spectrometry and proteomic analysis.